Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (FY)Mar 31, 2025 | (Q1)Jun 30, 2024 | (FY)Mar 31, 2024 | (Q4)Mar 31, 2024 | (Q3)Dec 31, 2023 | (Q2)Sep 30, 2023 | (Q1)Jun 30, 2023 | (FY)Mar 31, 2023 | (Q4)Mar 31, 2023 | (Q3)Dec 31, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | -3.47%126.27B | 11.54%34.89B | -10.26%130.8B | -6.10%33.48B | -2.77%35.39B | -24.20%30.65B | -5.99%31.28B | 17.29%145.76B | 10.83%35.66B | 6.16%36.4B |
| Cost of revenue | -7.59%113.07B | -6.56%29.08B | -8.28%122.36B | -15.17%30.36B | 3.67%33.82B | -26.37%27.06B | 10.21%31.12B | 25.73%133.41B | 25.74%35.79B | 12.48%32.63B |
| Gross profit | 56.37%13.2B | 3,444.51%5.81B | -31.70%8.44B | 2,502.31%3.12B | -58.46%1.57B | -2.40%3.59B | -96.75%164M | -32.01%12.36B | -103.50%-130M | -28.57%3.77B |
| Operating expense | -17.08%7.57B | 17.70%2.27B | 9.91%9.13B | 50.60%3.12B | 2.72%2.12B | -16.33%1.96B | 5.46%1.93B | 8.41%8.31B | 1.17%2.07B | 10.62%2.06B |
| Selling and administrative expenses | -17.08%7.57B | ---- | 9.91%9.13B | ---- | ---- | ---- | ---- | 8.41%8.31B | ---- | ---- |
| -Selling and marketing expense | -15.76%2.66B | ---- | -13.26%3.15B | ---- | ---- | ---- | ---- | -0.03%3.64B | ---- | ---- |
| -General and administrative expense | -17.77%4.91B | ---- | 27.94%5.98B | ---- | ---- | ---- | ---- | 16.02%4.67B | ---- | ---- |
| Operating profit | 915.36%5.63B | 300.17%3.54B | -117.04%-690M | 100.05%1M | -132.32%-552M | 22.02%1.63B | -155.08%-1.77B | -61.47%4.05B | -232.47%-2.2B | -49.97%1.71B |
| Net non-operating interest income (expenses) | -51.34%-1.47B | -86.49%-345M | -60.80%-968M | -63.48%-291M | -42.01%-240M | -85.29%-252M | -55.46%-185M | -32.02%-602M | -60.36%-178M | -49.56%-169M |
| Non-operating interest income | -28.57%45M | -73.08%7M | -8.70%63M | -93.33%1M | -66.67%8M | 86.67%28M | 73.33%26M | 122.58%69M | 7.14%15M | 500.00%24M |
| Non-operating interest expense | 46.46%1.51B | 66.82%352M | 53.65%1.03B | 51.30%292M | 28.50%248M | 85.43%280M | 57.46%211M | 37.78%671M | 54.40%193M | 64.96%193M |
| Net investment income | -201.55%-588M | 17.60%274M | 12.43%579M | 697.92%383M | -645.45%-120M | -67.95%83M | 25.27%233M | 215.95%515M | -53.40%48M | -66.15%22M |
| Gain(Loss) on financial instruments designated as cash flow hedges | ||||||||||
| Gain(Loss) on derecognition of available-for-sale financial assets | -207.73%-683M | -104.17%-1M | 145.74%634M | 143.82%610M | 2.44B | -2.44B | 300.00%24M | -69,200.00%-1.39B | -13,820.00%-1.39B | 0 |
| Income from associates and other participating interests | 0 | 0 | -3,098.68%-9.72B | -3,536.54%-7.15B | -77.42%-605M | -246.13%-1.03B | -848.41%-943M | -390.32%-304M | 6,833.33%208M | -625.53%-341M |
| Special income (charges) | 84.86%-5.35B | -72.34%13M | -6,753.98%-35.3B | -2,343.26%-9.6B | -9,159.18%-4.54B | -48,095.45%-21.21B | 262.07%47M | -1,960.00%-515M | -373.49%-393M | -145.37%-49M |
| Less:Restructuring and mergern&acquisition | --419M | ---- | --0 | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Less:Other special charges | -128.87%-2.75B | 72.34%-13M | 3,257.04%9.53B | 3,056.17%5.11B | 8,834.69%4.38B | 104.55%90M | -262.07%-47M | 1,036.00%284M | 95.18%162M | 145.37%49M |
| Less:Write off | -70.20%7.68B | ---- | 11,053.25%25.76B | 1,843.29%4.49B | --159M | ---- | ---- | --231M | --231M | --0 |
| Other non-operating income (expenses) | -136.84%-28M | -23.20%-154M | 114.59%76M | 4.08%-47M | 59.81%-125M | -82.81%-521M | -133.11%-49M | 120.69%30M | ||
| Income before tax | 94.53%-2.48B | 222.42%3.33B | -3,775.47%-45.39B | -306.29%-16.09B | -390.77%-3.5B | -2,595.68%-23.09B | -188.53%-2.72B | -86.76%1.24B | -431.46%-3.96B | -66.12%1.2B |
| Income tax | -196.70%-1.03B | 491.67%710M | 140.91%1.06B | 123.04%129M | 674.05%1.01B | -148.56%-203M | -73.39%120M | -68.64%440M | -384.26%-560M | -70.09%131M |
| Net income | 96.86%-1.46B | 192.21%2.62B | -5,950.38%-46.45B | -376.95%-16.22B | -521.48%-4.51B | -4,604.13%-22.88B | -208.41%-2.84B | -89.98%794M | -440.78%-3.4B | -65.60%1.07B |
| Net income continuous operations | 96.86%-1.46B | 192.21%2.62B | -5,943.02%-46.45B | -376.98%-16.22B | -520.90%-4.51B | -4,613.21%-22.88B | -208.37%-2.84B | -89.96%795M | -440.78%-3.4B | -65.56%1.07B |
| Noncontrolling interests | ||||||||||
| Net income attributable to the company | 96.86%-1.46B | 192.21%2.62B | -5,950.38%-46.45B | -376.95%-16.22B | -521.48%-4.51B | -4,604.13%-22.88B | -208.41%-2.84B | -89.98%794M | -440.78%-3.4B | -65.60%1.07B |
| Preferred stock dividends | ||||||||||
| Other under preferred stock dividend | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net income attributable to common stockholders | 96.86%-1.46B | 192.21%2.62B | -5,950.38%-46.45B | -376.95%-16.22B | -521.48%-4.51B | -4,604.13%-22.88B | -208.41%-2.84B | -89.98%794M | -440.78%-3.4B | -65.60%1.07B |
| Gross dividend payment | ||||||||||
| Basic earnings per share | 97.04%-101.2 | 192.19%192.61 | -5,946.41%-3.42K | -376.95%-1.19K | -521.42%-332.46 | -4,605.96%-1.69K | -208.41%-208.92 | -89.97%58.52 | -440.85%-250.49 | -65.59%78.89 |
| Diluted earnings per share | 97.04%-101.2 | 192.19%192.61 | -5,946.41%-3.42K | -376.95%-1.19K | -521.50%-332.46 | -4,605.96%-1.69K | -208.41%-208.92 | -89.97%58.52 | -440.85%-250.49 | -65.60%78.8746 |
| Dividend per share | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0.00%75 | 0.00%75 | 0 |
| Currency Unit | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY |
| Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |